Innoviva, Inc. has grown revenue 9.8% a year over three years and 4.1% a year over five, with earnings per share compounding at 33%. Revenue growth, 3-year annual rate: +9.8% (Biotechnology median +21%). Revenue growth, 5-year rate: +4.1%, growth has picked up over the last three years. Earnings per share, 3-year rate: +33%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 17, FY2009 to FY2025, as filed.

INVAInnoviva, Inc.

HealthcareUSD

$21.24

$16.6752 weeks$24.24

Is it growing?

Is INVA growing?

Innoviva, Inc. has grown revenue 9.8% a year over three years and 4.1% a year over five, with earnings per share compounding at 33%.

+9.8%

Revenue growth, 3-year annual rate · Biotechnology median +21% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +4.1%
Revenue growth, 5-year rate · +9.8% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +33%
Earnings per share, 3-year rate · revenue +9.8% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed